Validation of a Prognostic Multivariable Prediction Model for Insufficient Clinical Response to Methotrexate in Early Rheumatoid Arthritis and Its Clinical Application in Evidencio.
Helen R GosseltMaxime M A VerhoevenMaurits C F J de RotteSaskia M F PluijmIttai B MullerGerrit JansenJanneke TekstraMaja Bulatović-ĆalasanSandra G HeilFloris P J G LafeberJohanna M W HazesRobert de JongePublished in: Rheumatology and therapy (2020)
The U-Act-Early is registered at ClinicalTrials.gov. number: NCT01034137. tREACH is registered retrospectively at ISRCTN registry, number: ISRCTN26791028 at 23 August 2007.